DNA samples from patients in the federally funded Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial have revealed two genetic markers that appear to be associated with the emergence of suicidal thoughts during treatment with citalopram, a selective serotonin reuptake inhibitor (SSRI) antidepressant. [click link for full article]
From: www.medicalnewstoday.com
Risk Of New Suicidal Thoughts During Antidepressant Treatment Has Genetic Component, New AJP Study Shows
Posted by Ruslan Abuzant at 9:33 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment